Synthomer plc (LON:SYNT - Get Free Report) insider Lily Liu acquired 20,000 shares of the stock in a transaction that occurred on Tuesday, August 5th. The stock was acquired at an average cost of GBX 64 ($0.86) per share, for a total transaction of £12,800 ($17,213.56).
Synthomer Price Performance
Synthomer stock traded up GBX 1.20 ($0.02) during mid-day trading on Thursday, hitting GBX 64.40 ($0.87). 1,625,547 shares of the company were exchanged, compared to its average volume of 756,234. The company has a market capitalization of £105.60 million, a PE ratio of -1.29, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The business has a fifty day moving average of GBX 99.81 and a 200 day moving average of GBX 109.72. The company has a quick ratio of 0.97, a current ratio of 1.90 and a debt-to-equity ratio of 78.27. Synthomer plc has a 1-year low of GBX 61 ($0.82) and a 1-year high of GBX 266 ($3.58).
Synthomer (LON:SYNT - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported GBX (5.40) (($0.07)) earnings per share (EPS) for the quarter. Synthomer had a negative return on equity of 7.52% and a negative net margin of 4.40%. As a group, sell-side analysts expect that Synthomer plc will post 12.962963 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the stock. Jefferies Financial Group reaffirmed a "hold" rating and set a GBX 100 ($1.34) price target on shares of Synthomer in a report on Tuesday. Berenberg Bank decreased their price objective on shares of Synthomer from GBX 120 ($1.61) to GBX 80 ($1.08) and set a "hold" rating for the company in a report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on Synthomer from GBX 140 ($1.88) to GBX 115 ($1.55) and set a "hold" rating for the company in a research note on Wednesday, July 30th.
Get Our Latest Stock Analysis on Synthomer
Synthomer Company Profile
(
Get Free Report)
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.
Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.
See Also
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.